Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.

Clin Transl Sci · 2017 · PMC5351012 · PMID 27806191

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

modestly significantno p-value reported

A modestly significant 58% reduction vs. placebo in sputum elastase was observed with acebilustat treatment.

also in 257 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.